DCGI’s SEC to meet today to examine Bharat’s Biotech’s application on intanasal Covid vaccine as booster jab

New Delhi, Jan 04: The Subject Expert Committee (SEC) of the Drugs Controller General of India (DCGI) will meet today to examine Bharat Biotech’s application for the use of its intranasal Covid-19 vaccine as a booster shot, ANI reported citing sources.

Source: India News, India Breaking News, Latest news headlines in India – Oneindia News